Sun Pharma Advanced Research Co Ltd SPARC-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 3:29 PM IST
163.65quote price arrow down-4.65 (-2.76%)
Volume
657,200
52 week range
81.00 - 209.70

...

Loading . . .

KEY STATS

  • Open166.95
  • Day High170.00
  • Day Low163.00
  • Prev Close168.30
  • 52 Week High209.70
  • 52 Week High Date01/05/21
  • 52 Week Low81.00
  • 52 Week Low Date03/25/20
  • Market Cap634.68M
  • Shares Out262.1M
  • 10 Day Average Volume503,708.83
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change5.89

RATIOS/PROFITABILITY

  • EPS (TTM)-7.41
  • P/E (TTM)-22.08
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Sun Pharma Advanced Research Co Ltd News

There is no recent news for this security.

Latest SPARC-IN News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Sun Pharma Advanced Research Company Limited is engaged in the research and experimental development on natural sciences and engineering (Pharmacy). The Company operates through Pharmaceuticals Research & Development segment. Its programs include Xelpros, Elepsia XR, Baclofen GRS, Paclitaxel Injection Concentrate for Nanodispersion (Taclantis), Salmeterol - Fluticasone Dry Powder Inhaler (DPI), SUN-K706, Brimonidine OD, Tizanidine ER, Minocycline Topical and SUN-597 Topical....
Dilip Shanghvi
Chairman
Anil Raghavan
Chief Executive Officer
Chetan Rajpara
Chief Financial Officer
Address
17B Mahal Industrial Estate
Mahakali Caves Road, Andheri (East)
Mumbai
400093
India